Brief: Genscript Biotech's Unit Legend Biotech Entered Deal With Investment Adviser To Sell ADSs
08/05/2023 02:38
May 8 (Reuters) - Genscript Biotech Corp 1548.HK :
* UNIT, LEGEND BIOTECH ENTERED INTO PURCHASE AGREEMENT WITH
INVESTMENT ADVISER AND PURCHASERS
* LEGEND BIOTECH TO SELL AGGREGATE OF 5,468,750 ADSS AT A
PURCHASE
PRICE OF US$64.00 PER ADS
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale